Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation
- Eileen M. Bauer,
- Yan Qin,
- Thomas W. Miller,
- Russell W. Bandle,
- ,
- Patrick J. Pagano
- University of Pittsburgh,
- National Institutes of Health,
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOpen access
Abstract
<p>AimsThrombospondin-1 (TSP1), via its necessary receptor CD47, inhibits nitric oxide (NO)-stimulated soluble guanylate cyclase activation in vascular smooth muscle cells, and TSP1-null mice have increased shear-dependent blood flow compared with wild-type mice. Yet, the endothelial basement membrane should in theory function as a barrier to diffusion of soluble TSP1 into the arterial smooth muscle cell layer. These findings suggested that endothelial-dependent differences in blood flow in TSP1-null mice may be the result of direct modulation of endothelial NO synthase (eNOS) activation by circulating TSP1. Here we tested the hypothesis that TSP1 inhibits eNOS activation and endothelial-dependent arterial relaxation.Methods and resultsAcetylcholine (ACh)-stimulated activation of eNOS and agonist-driven calcium transients in endothelial cells were inhibited by TSP1. TSP1 also inhibited eNOS phosphorylation at serine<sup>1177</sup>. TSP1 treatment of the endothelium of wild-type and TSP1-null but not CD47-null arteries inhibited ACh-stimulated relaxation. TSP1-null vessels demonstrated greater endothelial-dependent vasorelaxation compared with the wild type. Conversely, TSP1-null arteries demonstrated less vasoconstriction to phenylephrine compared with the wild type, which was corrected upon inhibition of eNOS. In TSP1-null mice, intravenous TSP1 blocked ACh-stimulated decreases in blood pressure, and both intravenous TSP1 and a CD47 agonist antibody acutely elevated blood pressure in mice.ConclusionTSP1, via CD47, inhibits eNOS activation and endothelial- dependent arterial relaxation and limits ACh-driven decreases in blood pressure. Conversely, intravenous TSP1 and a CD47 antibody increase blood pressure. These findings suggest that circulating TSP1, by limiting endogenous NO production, functions as a pressor agent supporting blood pressure.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 471-481 (11 pages)Journal (Volume, Issue Number)
Cardiovascular Research (Volume 88, Issue 3)Publication milestones
- Published - 12/01/2010
Publication status
Published - 12/01/2010
ISSN
0008-6363Publication IDs
- Scopus: 78149288324
- PubMed: 20610415
Publication metrics
Metrics
SciVal
citations
79
Fractional count
1
Fractional count
0.10
Fractional count
9
Fractional count
0.90
Fractional count
1
Fractional count
1
SciVal
FWCI
2.03
SciVal
Author count
10
SciVal
Paper percentile
95
SciVal
Top percentile
5
PlumX, opens in new tab
Citation count
123
Captures
61
Mentions
1
Funding Details
NIH grant K22 CA128616 (J.S.I.) and Intramural Research Program of the NIH, NCI, Center for Cancer Research (D.D.R.), and NIDDK (J.S.).
FundersFunding number
NIH
-NCI
-NIDDK
ZIADK043408
